Items where Author is "Liu, Bai Cheng"

Group by: Item Type | No Grouping
Number of items: 1.

Li, Chen and Ding, Yi and Cai, Shanshan and Liu, Bai Cheng and Wang, Xiufeng (2025) Post-marketing safety concerns with Tislelizumab : a disproportionality analysis of the FDA adverse event reporting system. Frontiers in Immunology, 16: 1596842. ISSN 1664-3224

This list was generated on Thu Jun 19 16:09:28 2025 UTC.